Hereditary Angioedema (HAE) Highlights from ACAAI 2021 Annual Meeting

This accredited CME activity provides a summary of the latest information about hereditary angioedema (HAE) that was presented at the American College of Allergy, Asthma, & immunology 2021 Annual Scientific Meeting (ACAAI 2021). Since the Covid-19 pandemic limited the ability for specialists to attend ACAAI 2021 and discuss this latest research, this program provides an expert review of the most clinically-relevant information on HAE presented during the meeting.

HAE is a rare genetic disease that results in immunologic attacks that can be life threatening. Since HAE requires a team approach to care, this program will also benefit clinicians who may be involved in the care of patients with HAE but who don’t typically attend the ACAAI annual meeting.